CFMS Conformis Inc

Price (delayed)

$0.3861

Market cap

$71.59M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.04

Enterprise value

$16.74M

Conformis is a medical technology company that uses its proprietary iFit® Image-to-Implant® technology platform to develop, manufacture, and sell joint replacement implants and instruments that are individually sized and shaped, ...

Highlights
Conformis's gross profit has surged by 100% YoY
The EPS has surged by 87% year-on-year
Conformis's net income has plunged by 188% from the previous quarter but it has soared by 74% YoY
Conformis's quick ratio has surged by 52% YoY but it has decreased by 6% QoQ
The equity has contracted by 14% from the previous quarter

Key stats

What are the main financial stats of CFMS
Market
Shares outstanding
185.43M
Market cap
$71.59M
Enterprise value
$16.74M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.83
Price to sales (P/S)
0.68
EV/EBIT
N/A
EV/EBITDA
7.24
EV/Sales
0.16
Earnings
Revenue
$101.58M
EBIT
-$3.48M
EBITDA
$2.31M
Free cash flow
-$19.61M
Per share
EPS
-$0.04
Free cash flow per share
-$0.11
Book value per share
$0.46
Revenue per share
$0.57
TBVPS
$0.72
Balance sheet
Total assets
$128.78M
Total liabilities
$42.79M
Debt
$28.42M
Equity
$85.99M
Working capital
$94.8M
Liquidity
Debt to equity
0.33
Current ratio
6.84
Quick ratio
5.79
Net debt/EBITDA
-23.72
Margins
EBITDA margin
2.3%
Gross margin
64.2%
Net margin
-6.8%
Operating margin
-15.6%
Efficiency
Return on assets
-4.6%
Return on equity
-6.5%
Return on invested capital
-5.3%
Return on capital employed
-3.1%
Return on sales
-3.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CFMS stock price

How has the Conformis stock price performed over time
Intraday
0.84%
1 week
40.25%
1 month
-7.57%
1 year
-66.72%
YTD
-49.29%
QTD
-38.11%

Financial performance

How have Conformis's revenue and profit performed over time
Revenue
$101.58M
Gross profit
$65.25M
Operating income
-$15.85M
Net income
-$6.94M
Gross margin
64.2%
Net margin
-6.8%
Conformis's net income has plunged by 188% from the previous quarter but it has soared by 74% YoY
Conformis's net margin has shrunk by 183% QoQ but it has surged by 83% YoY
Conformis's gross profit has surged by 100% YoY
Conformis's operating margin has surged by 61% YoY

Growth

What is Conformis's growth rate over time

Valuation

What is Conformis stock price valuation
P/E
N/A
P/B
0.83
P/S
0.68
EV/EBIT
N/A
EV/EBITDA
7.24
EV/Sales
0.16
The EPS has surged by 87% year-on-year
The stock's price to book (P/B) is 77% less than its 5-year quarterly average of 3.6 and 48% less than its last 4 quarters average of 1.6
The equity has contracted by 14% from the previous quarter
The stock's price to sales (P/S) is 60% less than its last 4 quarters average of 1.7 and 51% less than its 5-year quarterly average of 1.4
Conformis's revenue has surged by 54% YoY

Efficiency

How efficient is Conformis business performance
CFMS's return on assets has dropped by 188% since the previous quarter but it has surged by 84% year-on-year
CFMS's return on equity has dropped by 183% since the previous quarter but it has surged by 92% year-on-year
The return on sales has surged by 91% year-on-year
The company's return on invested capital has surged by 90% YoY

Dividends

What is CFMS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CFMS.

Financial health

How did Conformis financials performed over time
The company's current ratio has surged by 58% YoY but it fell by 3.1% QoQ
Conformis's quick ratio has surged by 52% YoY but it has decreased by 6% QoQ
Conformis's debt is 67% lower than its equity
Conformis's debt to equity has increased by 18% QoQ but it has decreased by 6% YoY
The equity has contracted by 14% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.